Loading clinical trials...
Loading clinical trials...
This study is to evaluate the safety, tolerability and immunogenicity of single, ascending or multiple fixed subcutaneous and intravenous administrations of PF 05335810 to hypercholesterolemic subject...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT06568601 · Hypercholesterolemia
NCT00353782 · Hypercholesterolemia, Atherosclerosis
NCT07489209 · Homozygous Familial Hypercholesterolemia (HoFH)
NCT07037771 · Homozygous Familial Hypercholesterolemia
Pfizer Investigational Site
New Haven, Connecticut
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
South Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions